Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi study

INTRODUCTION: High-dose methotrexate (HDMTX) is administered for the treatment of some cancers. HDMTX is usually safe but may crystallize in renal tubules causing acute kidney injury (AKI). Consequently, MTX elimination is delayed, resulting in a severe and life-threatening condition. No studies hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Gros, Luis, Roldán, Alicia, Cabero-Martínez, Almudena, Domínguez-Pinilla, Nerea, de la Fuente, Adolfo, González-Barca, Eva, Tasso, María, Torrent, Montserrat, Gallardo, Eva, del Cerro, Inés, Giró-Perafita, Ariadna, Badia, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273868/
https://www.ncbi.nlm.nih.gov/pubmed/35147457
http://dx.doi.org/10.1177/10781552221079568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273868/
https://www.ncbi.nlm.nih.gov/pubmed/35147457
http://dx.doi.org/10.1177/10781552221079568

Ejemplares similares